Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's lymphoma

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Mhaidat, Nizar M ^a   Alshogran, Osama Y ^a   Khabour, Omar F ^a   Alzoubi, Karem H ^a   Matalka, Ismail I ^a   Haddadin, William J ^b   Mahasneh, Ibraheem O ^c   Aldaher, Ahmad N ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b KING HUSSEIN MEDICAL CENTER   (Jordan)

^c Royal Jordanian Medical Service   (Jordan)

Author keywords

C3435T SNP; Lymphoma; MDR 1

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; VINBLASTINE; ABCB1 PROTEIN, HUMAN; GLYCOPROTEIN P;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TREATMENT RESPONSE; BIOSYNTHESIS; CASE CONTROL STUDY; DRUG RESISTANCE; GENETICS; METABOLISM; MULTIDRUG RESISTANCE; NUCHAL CORD; PREDICTIVE VALUE; RISK FACTOR;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GENOTYPE; HODGKIN DISEASE; HUMANS; MALE; NUCHAL CORD; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; YOUNG ADULT;

EID: 79960560071     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-68     Document Type: Article

References (36)

1. Update on Lymphoma. C Morley-Jacob, E Gallop-Evans, Pediatrics and child health 2008 18 3
2. Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment. A Rueda, D Olmos, R Viciana, E and Alba, Clin Lymphoma Myeloma 2006 6 389 392 10.3816/CLM.2006.n.015 16640815
3. Lymphomas. L Castagna, M Magagnoli, M Demarco, A and Santoro, update on cancer therapeutics 2007 101 110 (Pubitemid 47386050)
4. Salvage therapy for Hodgkin's lymphoma. F Quddus, JO Armitage, Cancer J 2009 15 161 163 10.1097/PPO.0b013e3181a1438a 19390313
5. Multicellular resistance: a paradigm for clinical resistance? B Desoize, J Jardillier, Crit Rev Oncol Hematol 2000 36 193 207 10.1016/S1040-8428(00) 00086-X 11033306
6. Molecular mechanisms of drug resistance. DB Longley, PG Johnston, J Pathol 2005 205 275 292 10.1002/path.1706 15641020 (Pubitemid 40227997)
7. P-glycoprotein: from genomics to mechanism. SV Ambudkar, C Kimchi-Sarfaty, ZE Sauna, MM and Gottesman, Oncogene 2003 22 7468 7485 10.1038/sj.onc.1206948 14576852 (Pubitemid 37487170)
8. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. H Burger, JA Foekens, MP Look, ME Meijer-van Gelder, JG Klijn, EA Wiemer, G Stoter, K Nooter, Clin Cancer Res 2003 9 827 836 12576456 (Pubitemid 36182621)
9. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. T Ishikawa, H Hirano, Y Onishi, A Sakurai, S and Tarui, Drug Metab Pharmacokinet 2004 19 1 14 10.2133/dmpk.19.1 15499164
10. Possible prediction of the efficiency of chemotherapy in patients with lymphoproliferative diseases based on MDR1 gene G2677T and C3435T polymorphisms. OB Goreva, AY Grishanova, OV Mukhin, NP Domnikova, VV Lyakhovich, Bull Exp Biol Med 2003 136 183 185 14631505 (Pubitemid 38132989)
11. Response assessment in lymphoma. FA Hampson, AS Shaw, Clin Radiol 2008 63 125 135 10.1016/j.crad.2007.10.005 18194687
12. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. I Cascorbi, T Gerloff, A Johne, C Meisel, S Hoffmeyer, M Schwab, E Schaeffeler, M Eichelbaum, U Brinkmann, I Roots, Clin Pharmacol Ther 2001 69 169 174 10.1067/mcp.2001.114164 11240981 (Pubitemid 32225417)
13. The Reed-Sternberg cell in classical Hodgkin's disease. WC Chan, Hematol Oncol 2001 19 1 17 10.1002/hon.659 11276042 (Pubitemid 32267843)
14. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. M Tanabe, I Ieiri, N Nagata, K Inoue, S Ito, Y Kanamori, M Takahashi, Y Kurata, J Kigawa, S Higuchi, N Terakawa, K Otsubo, J Pharmacol Exp Ther 2001 297 1137 1143 11356939 (Pubitemid 32472514)
15. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. C Balram, A Sharma, C Sivathasan, EJ Lee, Br J Clin Pharmacol 2003 56 78 83 10.1046/j.1365-2125.2003. 01820.x 12848778 (Pubitemid 36886491)
16. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. M Kurzawski, M Drozdzik, J Suchy, G Kurzawski, M Bialecka, W Gornik, J Lubinski, Eur J Clin Pharmacol 2005 61 389 394 10.1007/s00228-005- 0926-5 15912392 (Pubitemid 41569314)
17. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. B Chowbay, S Cumaraswamy, YB Cheung, Q Zhou, EJ Lee, Pharmacogenetics 2003 13 89 95 10.1097/00008571-200302000-00005 12563178 (Pubitemid 36259588)
18. Polymorphisms of the Gene Encoding Multidrug Resistance Protein 1 in Taiwanese. MJ Huang, LC Yung, YC Chang, YH Yang, SH Ching, Journal of Food and Drug Analysis 2005 13 112 117
19. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. MM Ameyaw, F Regateiro, T Li, X Liu, M Tariq, A Mobarek, N Thornton, GO Folayan, J Githang'a, A Indalo, D Ofori-Adjei, DA Price-Evans, HL McLeod, Pharmacogenetics 2001 11 217 221 10.1097/00008571- 200104000-00005 11337937 (Pubitemid 32319871)
20. Genotype and allele frequencies of C3435T polymorphism of the MDR1 gene in various Jewish populations of Israel. O Ostrovsky, A Nagler, M Korostishevsky, E Gazit, H Galski, Ther Drug Monit 2004 26 679 684 10.1097/00007691-200412000-00015 15570194 (Pubitemid 39579151)
21. The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis. A Farnood, N Naderi, SJ Moghaddam, B Noorinayer, F Firouzi, R Aghazadeh, NE daryani, MR Zali, Int J Colorectal Dis 2007 22 999 1003 10.1007/s00384-007-0270-6 17242936 (Pubitemid 47500239)
22. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. K Jamroziak, W Mlynarski, E Balcerczak, M Mistygacz, J Trelinska, M Mirowski, J Bodalski, T Robak, Eur J Haematol 2004 72 314 321 10.1111/j.1600-0609.2004. 00228.x 15059065 (Pubitemid 38520728)
23. Polymorphisms of the MDR1 gene in the Czech population. K Pechandova, H Buzkova, O Slanar, F Perlik, Folia Biol (Praha) 2006 52 184 189 17184596 (Pubitemid 46020161)
24. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. O Landgren, NE Caporaso, Hematol Oncol Clin North Am 2007 21 825 840 10.1016/j.hoc.2007.07.001 17908622 (Pubitemid 47496094)
25. MDR1 C3435T polymorphism in patients with breast cancer. S Turgut, A Yaren, R Kursunluoglu, G Turgut, Arch Med Res 2007 38 539 544 10.1016/j.arcmed.2007.02.005 17560460 (Pubitemid 46873813)
26. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. M Siegsmund, U Brinkmann, E Schaffeler, G Weirich, M Schwab, M Eichelbaum, P Fritz, O Burk, J Decker, P Alken, U Rothenpieler, R Kerb, S Hoffmeyer, H Brauch, J Am Soc Nephrol 2002 13 1847 1854 10.1097/01.ASN.0000019412.87412.BC 12089380 (Pubitemid 34700609)
27. Association of C3435T single-nucleotide polymorphism of MDR1 gene with breast cancer in an Iranian population. F Tatari, R Salek, F Mosaffa, A Khedri, J Behravan, DNA Cell Biol 2009 28 259 263 10.1089/dna.2008.0826 19388849
28. Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients. P Kaya, U Gunduz, F Arpaci, AU Ural, S Guran, Am J Hematol 2005 80 26 34 10.1002/ajh.20427 16138358 (Pubitemid 41254264)
29. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. KY Urayama, JK Wiencke, PA Buffler, AP Chokkalingam, C Metayer, JL Wiemels, Cancer Epidemiol Biomark Prev 2007 16 1172 1177 10.1158/1055-9965.EPI-07-0007 (Pubitemid 46984955)
30. MDR1 single nucleotide polymorphism C3435T in normal colorectal tissue and colorectal carcinomas detected by MALDI-TOF mass spectrometry. A Humeny, F Rödel, C Rödel, R Sauer, L Füzesi, C Becker, T Efferth, Anticancer Res 2003 23 2735 40 12894567 (Pubitemid 36897152)
31. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. AK Larsen, AE Escargueil, A Skladanowski, Pharmacol Ther 2000 85 217 229 10.1016/S0163-7258(99)00073-X 10739876 (Pubitemid 30160791)
32. MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. JH Pan, JX Han, JM Wu, HN Huang, QZ Yu, LJ Sheng, Respiration 2009 78 49 55 10.1159/000158454 18812689
33. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer. JH Pan, JX Han, JM Wu, LJ Sheng, HN Huang, QZ Yu, Respiration 2008 75 380 385 10.1159/000108407 17851225 (Pubitemid 351685428)
34. MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. JW Sohn, SY Lee, SJ Lee, EJ Kim, SI Cha, CH Kim, JT Lee, TH Jung, JY Park, Jpn J Clin Oncol 2006 36 137 141 10.1093/jjco/hyi231 16478794
35. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. T Illmer, US Schuler, C Thiede, UI Schwarz, RB Kim, S Gotthard, D Freund, U Schakel, G Ehninger, M Schaich, Cancer Res 2002 62 4955 4962 12208746 (Pubitemid 34984419)
36. MDR1 polymorphism influences the outcome of multiple myeloma patients. G Buda, V Maggini, S Galimberti, A Martino, N Giuliani, F Morabito, G Genestreti, P Iacopino, V Rizzoli, R Barale, AM Rossi, M Petrini, Br J Haematol 2007 137 454 456 10.1111/j.1365-2141.2007.06605.x 17488488 (Pubitemid 46698294)